SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-042463
Filing Date
2018-08-07
Accepted
2018-08-07 16:42:12
Documents
42
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499077_10q.htm 10-Q 504786
2 EXHIBIT 10.1 tv499077_ex10-1.htm EX-10.1 7897
3 EXHIBIT 31.1 tv499077_ex31-1.htm EX-31.1 10242
4 EXHIBIT 31.2 tv499077_ex31-2.htm EX-31.2 10106
5 EXHIBIT 32.1 tv499077_ex32-1.htm EX-32.1 3954
6 EXHIBIT 32.2 tv499077_ex32-2.htm EX-32.2 3828
  Complete submission text file 0001144204-18-042463.txt   2960907

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cik0001651407-20180630.xml EX-101.INS 614232
8 XBRL TAXONOMY EXTENSION SCHEMA cik0001651407-20180630.xsd EX-101.SCH 28234
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cik0001651407-20180630_cal.xml EX-101.CAL 16536
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cik0001651407-20180630_def.xml EX-101.DEF 185519
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cik0001651407-20180630_lab.xml EX-101.LAB 185080
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cik0001651407-20180630_pre.xml EX-101.PRE 207356
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 18998686
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences